首页> 外文期刊>Investigative ophthalmology & visual science >Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor.
【24h】

Inhibition of retinal detachment-induced apoptosis in photoreceptors by a small peptide inhibitor of the fas receptor.

机译:通过fas受体的小肽抑制剂抑制视网膜脱离诱导的感光细胞凋亡。

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose. To test the effect of a small peptide inhibitor (Met12) of the Fas receptor on the activation of extrinsic and intrinsic apoptosis pathways after retinal detachment. Methods. Retinal-RPE separation was created in Brown Norway rats by subretinal injection of 1% hyaluronic acid. Met12, derived from the Fas-binding extracellular domain of the oncoprotein Met, was injected into the subretinal space at the time of separation. A mutant peptide and vehicle administered in a similar fashion acted as inactive controls. The extrinsic apoptotic pathway was induced in 661W cells using a Fas-activating antibody in the presence or absence of Met12. Caspase 3, caspase 8, and caspase 9 activities were measured with calorimetric and luminescent assays in retinal extracts and cell lysates. Terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) was performed in retinal sections 3 days after separation. Histology was performed in retinal sections 2 months after retinal detachment. Results. Met12 inhibited Fas-induced caspase 8 activation in 661W cells. Similarly, administration of Met12 into the subretinal space inhibited the activation of caspase 3, caspase 8, and caspase 9 after retinal detachment. This corresponded to a decreased level of TUNEL-positive staining of photoreceptors after retinal-RPE separation in animals that received Met12, but not inactive mutant, peptide treatment. After 2 months, the outer nuclear layer was significantly thicker, and the photoreceptor count was higher in animals treated with subretinal Met12. Conclusions. The small peptide Met12 may serve as a photoreceptor-protective agent in the setting of retinal-RPE separation.
机译:目的。测试Fas受体的一种小肽抑制剂(Met12)对视网膜脱离后外源性和内在性凋亡通路激活的影响。方法。通过视网膜下注射1%透明质酸在布朗挪威大鼠中产生视网膜RPE分离。分离时将源自癌蛋白Met的Fas结合细胞外结构域的Met12注入视网膜下腔。以类似方式施用的突变肽和运载体充当失活对照。在存在或不存在Met12的情况下,使用Fas激活抗体在661W细胞中诱导外源性凋亡途径。用比色法和发光法测定视网膜提取物和细胞裂解物中的胱天蛋白酶3,胱天蛋白酶8和胱天蛋白酶9的活性。分离后3天,在视网膜切片中进行末端脱氧核苷酸转移酶dUTP切口末端标记(TUNEL)。视网膜脱离2个月后在视网膜切片中进行组织学检查。结果。 Met12抑制661W细胞中Fas诱导的caspase 8活化。同样,在视网膜脱离后向视网膜下间隙施用Met12可抑制caspase 3,caspase 8和caspase 9的活化。这对应于接受Met12而非无活性突变体肽治疗的动物在视网膜RPE分离后光感受器的TUNEL阳性染色水平降低。 2个月后,在视网膜下Met12治疗的动物中,外核层明显增厚,并且感光细胞数量更高。结论小肽Met12可以在视网膜-RPE分离的过程中充当光感受器保护剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号